Optimize early Hit Structures through iterative DMTA Cycles using Advanced Medicinal Chemistry
Original notice title
Belgium – Research and experimental development services – QMMO26-4194 - Appointment of a CRO to optimize early Hit Structures through iterative DMTA Cycles (Design – Make – Test – Analysis) using Advanced Medicinal Chemistry
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
50 / 100
Risk factors
No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.
Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Services contract
- 1 lot
- Duration 1 YEAR
- Perform iterative Design-Make-Test-Analyze (DMTA) cycles for optimization of early hit structures.
- Apply advanced medicinal chemistry techniques.
Show full summary
Single-lot negotiated procedure for appointing a Contract Research Organization (CRO) to optimize early hit structures through iterative Design-Make-Test-Analyze (DMTA) cycles in advanced medicinal chemistry. The buyer is KU Leuven, acting for itself and VIB. The contract duration is 1 year. No estimated value is provided. The procedure is a competitive negotiation without prior call (neg-w-call), likely limiting candidates to 3-4. Award criteria (price and quality) will be detailed in the second stage. The tender is published in English, with submission via the e-procurement platform. EU funding status is inconsistent: structured data indicates EU-funded, but the XML notice states no EU funds.
Risks
No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.
Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- CRO must be capable of conducting advanced medicinal chemistry DMTA cycles.
Administrative
- Electronic submission via the e-procurement platform is required.
- Tender must be submitted in English (notice language).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Leuven, BEL
Buyer profile
Identifier
0419052173_5132
Activity
Education
Lots (1)
LOT-0001
Optimize early Hit Structures through iterative DMTA Cycles using Advanced Medicinal Chemistry
Appointment of a CRO to perform iterative DMTA cycles (Design-Make-Test-Analyze) for optimizing early hit structures in advanced medicinal chemistry. The contract is for services related to research and experimental development (CPV 73100000). Duration: 1 year. Place of performance: Leuven, Belgium (BE242).
Location
Duration
Category
Award Criteria
Deadline
Award details
The contracting authority will determine the most economically advantageous tender taking into account the best value for money. The precise award criteria will be set out in the specifications at the second stage of the procurement procedure.
Value note
Show original TED data
Original lot title
QMMO26-4194 - Appointment of a CRO to optimize early Hit Structures through iterative DMTA Cycles (Design – Make – Test – Analysis) using Advanced Medicinal Chemistry
Original TED description
QMMO26-4194 - Appointment of a CRO to optimize early Hit Structures through iterative DMTA Cycles (Design – Make – Test – Analysis) using Advanced Medicinal Chemistry
Procurement Details
- Publication date
- 08 Jul 2026
- Languages
- Dutch, English
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 473822-2026
Documents (2)
Similar tenders
Spain – Research and experimental development services – Pre-commercial Procurement of an innovative Systemic Sustainability Transition Solution for Health Care Organisations (suHCO)
Belgium – Research and experimental development services – Long-term API stockpiling and rapid finished dose form manufacture
Spain – Accounting, auditing and fiscal services – SDA servicios profesionales especializados
Norway – Research and development services and related consultancy services – Dynamic procurement scheme for biology and popular science assistance.
Norway – Architectural, construction, engineering and inspection services – Dynamic Purchasing System (DIO) procurement of consultancy services
Sweden-Uppsala: Research services
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
50 / 100
Risk factors
No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.
Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications